RG-13022 is a Tyrosine kinase tyrphostin. Reports indicate that RG-13022 suppresses epidermal growth factor (EGF)-stimulated cancer cell proliferation in cancer cell studies. Additionally, RG-13022 has been described to inhibit EGF, platelet-dervied growth (PDGF) signaling, and PDGF enhanced DNA synthesis. RG-13022 is an inhibitor of EGFR and PDGFR.
Specifications and Purity: ≥98%
Molecular Formula: C16H14N2O2
Molecular Weight: 266.3
PubChem CID: 5353927
Isomeric SMILES: COC1=C(C=C(C=C1)/C=C(/C#N)/C2=CN=CC=C2)OC
Related Documents: https://aladdin-for-icloud-store.oss-cn-hangzhou.aliyuncs.com/aladdinsci/pdp/sds/1/R337829-SCI_12783dbe5478177b09eaed5db210d1a6.pdf
- UPC:
- 41116105
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- R337829-10mg
- CAS:
- 136831-48-6
- Product Size:
- 10mg
akash.verma@cenmed.com
(732) 447-1115





